Strongyloidiasis

Strongyloidiasis is a human parasitic disease caused by the nematode Strongyloides stercoralis. Other Strongyloides include S. fülleborni, which infects chimpanzees and baboons and may produce limited infections in humans. (From the Wikpedia article Strongyloidiasis.)

Download PDF containing detailed information.

Recent Publications on Strongyloidiasis:
Fatal strongyloidiasis in three kidney recipients in Kuwait. OBJECTIVE: It was the aim of this study to report 3 rare fatal cases of...	29th October, 2009	Department of Microbiology,Faculty of Medicine, Kuwait University, Safat,	Med Princ Pract. 2009;18(5):414-7. Epub 2009 Jul 31. DOI Direct Link
[A case of severe strongyloidiasis] OBJECTIVE: To evaluate the diagnostic sensitivity and specificity of...	27th October, 2009		Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2009
Strongyloides stercoralis hyperinfection transmitted by liver allograft in a transplant recipient. We describe a case of Strongyloides stercoralis hyperinfection in a liver...	22nd October, 2009	Department of Infectious Diseases, Hospital Virgen del Rocio, Sevilla,	Am J Transplant. 2009 Nov;9(11):2637-40. DOI Direct Link
Histopathology of Strongyloides stercoralis hyperinfection during immune reconstitution in an HIV-infected patient. Concomitant parasitism is not uncommon especially in tropical countries...	16th October, 2009		AIDS. 2009 Jul 31;23(12):1609-11. DOI Direct Link
Strongyloidiasis in transplant patients. Strongyloides stercoralis is an intestinal nematode that can persist in...	8th October, 2009	Division of Allergy and Infectious Diseases, University of Washington,	Clin Infect Dis. 2009 Nov 1;49(9):1411-23. DOI Direct Link
→View more research publications.

Strongyloidiasis Clinical Trials:
Ivermectin Versus Albendazole for Chronic Strongyloidiasis

Strongyloidiasis Patents:
US Patent No.	Title
7238711	Compounds and methods to inhibit or augment an inflammatory response
7351739	Bioactive compounds and methods of uses thereof
7354932	Chemokine receptor binding heterocyclic compounds with enhanced efficacy
7354934	Chemokine receptor binding heterocyclic compounds with enhanced efficacy
7378409	Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Strongyloidiasis scientists - we have details of around 281 individuals working on Strongyloidiasis .